All public logs
Jump to navigation
Jump to search
Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)- 15:05, 26 November 2023 Jwarner talk contribs moved page Allogeneic HSCT to Allogeneic HSCT conditioning regimens over redirect
- 15:05, 26 November 2023 Jwarner talk contribs deleted redirect Allogeneic HSCT conditioning regimens by overwriting (Deleted to make way for move from "Allogeneic HSCT")
- 13:55, 26 November 2023 Jwarner talk contribs moved page Niraparib and Abiraterone (Akeega) to Niraparib and abiraterone (Akeega)
- 03:09, 26 November 2023 Jwarner talk contribs moved page Mycostatin (Nystatin) to Nystatin (Mycostatin) (error in brand naming)
- 18:15, 19 November 2023 Jwarner talk contribs created page Category:PARP2 inhibitors (Created page with "Category:PARP inhibitors")
- 18:15, 19 November 2023 Jwarner talk contribs created page Category:PARP1 inhibitors (Created page with "Category:PARP inhibitors")
- 18:05, 19 November 2023 Jwarner talk contribs created page Category:TYK2 inhibitors (Created page with "A member of the Janus kinase family of tyrosine kinases. Category:JAK inhibitors")
- 14:14, 18 November 2023 Jwarner talk contribs moved page Toripalimab (Loqtorz) to Toripalimab (Loqtorzi) (Brand name not spelled right)
- 15:10, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, third generation (Created page with "Category:Aromatase inhibitors")
- 15:09, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, second generation (Created page with "Category:Aromatase inhibitors")
- 15:08, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, first generation (Created page with "Category:Aromatase inhibitors")
- 15:03, 17 November 2023 Jwarner talk contribs created page Category:PMDA approved in 1995 (Created page with "Category:PMDA approved drugs")
- 14:26, 17 November 2023 Jwarner talk contribs moved page Anlotinib (AL-3818) to Anlotinib (Fukewei) (brand name)
- 12:32, 17 November 2023 Jwarner talk contribs moved page Capivasertib (AZD-5363) to Capivasertib (Truqap) (FDA approval)
- 11:50, 17 November 2023 Jwarner talk contribs created page Thyroid cancer, medullary - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:16, 15 November 2023 Jwarner talk contribs created page NCCN guidelines (Created page with "This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page. '''Given the rapid...")
- 00:44, 13 November 2023 Jwarner talk contribs created page Upper tract urothelial carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:12, 7 November 2023 Jwarner talk contribs created page Category:EMA approved in 1977 (Created page with "Category:EMA approved drugs")
- 17:12, 7 November 2023 Jwarner talk contribs moved page Bacillus Calmette-Guérin (BCG) to BCG vaccine (INN)
- 01:28, 7 November 2023 Jwarner talk contribs created page CRC (Redirected page to Colorectal cancer) Tag: New redirect
- 01:00, 7 November 2023 Jwarner talk contribs created page Category:Warm autoimmune hemolytic anemia medications (Created page with "Category:Classical hematology medications")
- 00:59, 7 November 2023 Jwarner talk contribs created page Category:EMA approved in 1955 (Created page with "Category:EMA approved drugs")
- 00:55, 7 November 2023 Jwarner talk contribs created page Category:Colorectal cancer medications (historic) (Created page with "Category:Colorectal cancer medications")
- 23:16, 6 November 2023 Jwarner talk contribs created page Category:Acquired hemophilia A medications (Created page with "Category:Acquired coagulopathy medications")
- 20:57, 6 November 2023 Jwarner talk contribs created page Mitomycin pyelocalyceal (Jelmyto) (Created page with "==Mechanism of action== Antibiotic oncologic isolated from Streptomyces caespitosus; inhibits DNA synthesis and induces crosslinking. Formulated for pyelocalyceal infusion. =...")
- 20:28, 6 November 2023 Jwarner talk contribs created page Lasofoxifene (Fablyn) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lasofoxifene NCI Drug Dictionary]: A non-steroidal, naphthalene-derived, thi...")
- 20:08, 6 November 2023 Jwarner talk contribs created page Fadrozole (Afema) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fadrozole-hydrochloride NCI Data Dictionary]: The hydrochloride salt of the...")
- 19:33, 6 November 2023 Jwarner talk contribs created page Dinutuximab beta (Qarziba) (Created page with "==Mechanism of action== Anti-GD2 antibody ==Diseases for which it is used== *Neuroblastoma ==History of changes in EMA indication== *2017-05-08: Initial authorisation as...")
- 19:04, 6 November 2023 Jwarner talk contribs created page Chlorozotocin (DCNU) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin NCI Drug Dictionary]: A glucose-linked chloroethylnitrosourea...")
- 18:59, 6 November 2023 Jwarner talk contribs created page Trastuzumab-zerc (Zercepac) (Created page with "'''Note: this is a trastuzumab biosimilar.''' ==Also known as== *'''Brand name:''' Zercepac Category:Drugs Category:Intravenous medications Category:Neutral C...")
- 18:59, 6 November 2023 Jwarner talk contribs created page Trastuzumab-herw (Herwenda) (Created page with "'''Note: this is a trastuzumab biosimilar.''' ==Also known as== *'''Brand name:''' Herwenda Category:Drugs Category:Intravenous medications Category:Neutral C...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rixi (Riximyo) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Riximyo Category:Drugs Category:Intravenous medications Category:Neutral Cate...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rixa (Rixathon) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Rixathon Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rite (Ritemvia) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Ritemvia Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-blit (Blitzima) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Blitzima Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:57, 6 November 2023 Jwarner talk contribs created page Bevacizumab-onbe (Onbevzi) (Created page with "'''Note: this is a bevacizumab biosimilar.''' ==Also known as== *'''Brand name:''' Onbevzi Category:Drugs Category:Intravenous medications Category:Neutral Ca...")
- 18:56, 6 November 2023 Jwarner talk contribs created page Bevacizumab-equi (Equidacent) (Created page with "'''Note: this is a bevacizumab biosimilar.''' ==Also known as== *'''Brand name:''' Equidacent Category:Drugs Category:Intravenous medications Category:Neutral [...")
- 18:56, 6 November 2023 Jwarner talk contribs created page Bevacizumab-aybi (Aybintio) (Created page with "'''Note: this is a bevacizumab biosimilar.'' ==Also known as== *'''Brand name:''' Aybintio Category:Drugs Category:Intravenous medications Category:Neutral Ca...")
- 13:59, 6 November 2023 Jwarner talk contribs created page Anlotinib (AL-3818) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/catequentinib-hydrochloride NCI Drug Dictionary]: The hydrochloride salt for...")
- 12:15, 6 November 2023 Jwarner talk contribs created page Cutaneous squamous cell carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 13:04, 5 November 2023 Jwarner talk contribs created page Systemic mastocytosis - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:54, 5 November 2023 Jwarner talk contribs created page Polycythemia vera - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:12, 5 November 2023 Jwarner talk contribs created page Meningioma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:07, 5 November 2023 Jwarner talk contribs created page B-cell lymphoma of mucosa-associated lymphoid tissue - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:00, 5 November 2023 Jwarner talk contribs created page B-cell lymphoma of mucosa-associated lymphoid tissue - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:36, 5 November 2023 Jwarner talk contribs created page JMML (Redirected page to Juvenile myelomonocytic leukemia) Tag: New redirect
- 00:14, 4 November 2023 Jwarner talk contribs moved page Fruquintinib (HMPL-013) to Fruquintinib (Elunate) (brand name)
- 20:52, 3 November 2023 Jwarner talk contribs created page Acute lymphoblastic leukemia, infant - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:49, 3 November 2023 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia, infant regimens (Created page with "Category:Acute lymphoblastic leukemia regimens")
- 20:48, 3 November 2023 Jwarner talk contribs created page Acute lymphoblastic leukemia, infant (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")